Welcome to our dedicated page for Citrine Global news (Ticker: CTGL), a resource for investors and traders seeking the latest updates and insights on Citrine Global stock.
Citrine Global Corp. (CTGL), doing business as SkyTech Orion Global Corp., generates news primarily around its activities in unmanned and drone defense systems. Company announcements focus on the development and launch of the SkyTech Replicator™ modular drone platform, the rollout of its Replication Manufacturing Method™, and progress on SkyTech Center, Israel’s National UAV and Drone Innovation & Manufacturing Hub led by its Israeli subsidiary SkyTech Orion Ltd.
Investors and industry observers following CTGL news will see coverage of defense and unmanned systems conferences such as AUVSI Defense in Washington, D.C., and UVID 2025 in Tel Aviv, where the company presents its modular drone platforms and manufacturing concepts. News items describe how the SkyTech Replicator™ platform is positioned for multi-mission roles and built with NDAA-compliant components and Western-aligned supply chains for use in the United States, Israel, NATO, and allied markets, subject to regulations.
Another recurring theme in CTGL news is the company’s dual-nation U.S.–Israel structure and its role in national initiatives. Releases highlight that SkyTech Orion Ltd. was selected to establish a national drone innovation and manufacturing center in Yeruham, designated as “The Drone City” by the Government of Israel, and that the project is supported by Israeli government entities.
Earlier news in the company’s history documents its activities in plant-based wellness and pharma solutions, including product lines such as Green Side by Side™ and GreenFeels™, provisional patent applications, and plans for the Green Vision Center Israel. For readers interested in CTGL’s evolution, the news archive provides context on its transformation from wellness and botanical products to unmanned systems and defense-grade drone solutions.
By reviewing CTGL news on this page, users can follow company statements on product launches, strategic shifts, national projects, conference participation, and key corporate communications such as shareholder letters and board changes.
SkyTech Orion Global Corp (CTGL) released an updated corporate presentation and letter to shareholders outlining its strategy to scale production of NDAA-compliant small drones for U.S., Israeli, and allied markets.
The company highlights a modular, scalable manufacturing model, planned U.S. local production, a multi‑million‑dollar Israeli government grant for an Innovation and Production Center, ongoing strategic partnerships and capital raises, and preparations for a Nasdaq uplisting, citing a $186 billion global market opportunity.
SkyTech Orion Global Corp (CTGL) on Dec. 12, 2025 provided a strategic update after exhibiting at major defense and manufacturing events in the United States, Europe, and Israel.
The company said its SkyTech Replicator™ modular drone family and Replication Manufacturing Method™ align with rising Western demand for NDAA‑compliant, rapidly manufacturable systems. SkyTech's Israeli subsidiary was selected to establish Israel's National Drone Innovation and Manufacturing Center, intended to enable transition from prototype to serial production and capacity for hundreds of thousands to millions of drones. The release cites Reuters reporting that the U.S. Army plans to buy 1 million drones, underscoring market demand for Western, scalable drone manufacturing.
Citrine Global Corp (CTGL), doing business as SkyTech Orion Global, announced that CEO and Chairwoman Ora Elharar Soffer will deliver a keynote at UVID 2025 on Nov 17, 2025.
The company will exhibit at Booth 14 and showcase the SkyTech Replicator™ modular drone platform and present the SkyTech Center, a planned national UAV innovation and large-scale manufacturing hub in Yeruham, Israel. The Replicator platform is described as a Plug & Fly™ modular system built with NDAA-compliant, U.S.-approved components to support distributed manufacturing across the U.S., Israel, and global partners.
The SkyTech Center initiative is supported by Israel’s Growth Administration and Ministry of Economy and aims to build Blue-and-White production capacity, strengthen exports, and expand U.S.–Israel industrial and defence collaboration.
Citrine Global Corp (OTCQB: CTGL) participated at AUVSI Defense 2025 in Washington, D.C. on Oct 29, 2025, where it launched the SkyTech Replicator™, a modular drone kit that converts into four mission drones and ships in a single tactical case.
The Replicator features a Smart Core Unit control hub, two Smart Arm classes (Light and Endura), swappable batteries, and modular payloads. Stated payload limits are up to 0.5 kg for light arms and up to 2.5 kg for endurance/lift arms. The system is described as tool-less, NDAA-compliant, cable-less, and designed for rapid “Plug & Fly” reconfiguration to deliver ISR, strike, lift, or loitering capabilities.
SkyTech Orion Global Corp. (OTCQB: CTGL) announced a strategic transformation into unmanned systems and defense-grade drone solutions, unveiling the modular SkyTech Replicator™ platform and a proprietary Replication Manufacturing Method.
Key developments: multiple patent filings in the U.S. and Israel (2025); a multi-million-dollar grant from the Israeli Ministry of Economy for the SkyTech Center Israel on ~11,687 sqm in Yeruham; a collaboration with Stratasys for additive manufacturing; and planned assembly centers in Israel and the U.S. to produce thousands of units in Q1 2026. The company is pursuing a strategic capital raise and an eventual NASDAQ uplist.
Summary not available.
Citrine Global Corp. (CTGL) has signed a memorandum of understanding (MOU) with MyPlant Bio Ltd. to acquire 55% of its shares for USD 2.44 million. This acquisition aligns with Citrine Global's strategy to lead in plant-based wellness and pharma solutions, leveraging MyPlant’s expertise in botanical drug development. The collaboration aims to enhance Citrine's product lines with scientifically backed formulations, tapping into the growing markets projected to reach USD 625 billion (nutritional supplements) and USD 53 billion (plant-derived drugs) by 2030 and 2026, respectively.
Citrine Global Corp. (OTCQB: CTGL) has filed a provisional patent application for compositions and methods aimed at mitigating side effects from medicinal treatments, aging, and unhealthy lifestyles. The patent, No: 63/418,046, focuses on solutions to common side effects like dryness, headaches, and fatigue. Additionally, the company has announced the launch of the GreenFeelsTM product lines, which include over 100 wellness products and nutritional supplements designed to enhance quality of life. The launch emphasizes plant-based solutions and targets both U.S. and global markets.
Citrine Global Corp. (OTCQB: CTGL) announced that its subsidiary, Cannovation Center Israel Ltd, has filed a provisional patent application with the USPTO. The application focuses on alleviating oral cavity side effects related to medications and unhealthy lifestyles. With over 25% of the population experiencing dry mouth, the company aims to develop plant-based wellness solutions, including their SmokLy™ sprays. Citrine Global's strategy revolves around innovative plant-based products, emphasizing infrastructure for production and sales across North America and Europe.
Citrine Global Corp. (OTCQB: CTGL) announced the appointment of Prof. Itamar Grotto to its Board of Directors and as President of Green Vision Center Israel. Prof. Grotto, a seasoned expert in public health, aims to advance the company's strategy in developing innovative plant-based wellness and pharma solutions. The company has acquired 125,000 square feet of land in southern Israel to establish the Green Vision Center, which will serve as a hub for production and innovation in the plant-based sector. This development is expected to enhance the company's infrastructure and market presence.